PharmaCan Capital Corp.
TSX VENTURE : MJN

PharmaCan Capital Corp.

January 13, 2015 07:00 ET

PharmaCan Capital Corp. to Open Toronto Stock Exchange

TORONTO, ONTARIO--(Marketwired - Jan. 13, 2015) -

Media Advisory & Photo Opportunity

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES

PharmaCan Capital Corp. (TSX VENTURE:MJN) ("PharmaCan") is pleased to announce that PharmaCan, led by PharmaCan's President & CEO, Paul Rosen, will open trading on Toronto Stock Exchange on January 13, 2015. PharmaCan, which has investments in 5 of the 23 Licensed Producers under Canada's Marihuana for Medical Purposes Regulations ("MMPR"), will be the first MMPR investment company in Canada to open trading of the Toronto Stock Exchange.

WHO: Paul Rosen, President & CEO, PharmaCan Capital
WHEN: January 13, 2015
9:00 am Arrival
9:15 am Opening Remarks
9:29:45 am 15 second count down to opening of the market
9:30 am Initiate the siren to open the market
9:35 am Interviews
WHERE: TMX Broadcast Centre
The Exchange Tower, 130 King Street West (The Studio at street level, east corner of King St West and York Street - parking entrance at York)

About PharmaCan Capital Corp.

PharmaCan is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations ("MMPR"). PharmaCan has a diversified portfolio of investments including investments in 5 of the 23 companies licensed by Heath Canada to produce medical marijuana.

PharmaCan's first investee company, The Peace Naturals Project ("Peace Naturals"), was the first new producer to be granted a license by Health Canada for the commercial production and distribution of medical cannabis under the MMPR. PharmaCan also has a significant minority interest in Whistler Medical Marijuana Company ("WMMC"), Canada's first and only certified organic producer of medical marijuana. Both Peace Naturals and WMMC are licensed to produce and sell medical cannabis. PharmaCan also owns 100% of In The Zone Produce Ltd., a licensed producer based in the Okanagan Valley. ITZ is licensed by Health Canada under the MMPR to produce and sell medical cannabis. In addition, PharmaCan has minority investments in two companies licensed to produce medical marijuana under the MMPR, ABcann and Hydropothecary. PharmaCan's other investments are in companies that are in the license application stage.

PharmaCan's President & CEO is Paul Rosen, who previously founded and was CEO of Skypad Inc., a custom contract furniture manufacturing company. Paul is a member of the Law Society of Upper Canada and previously practiced criminal and constitutional law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information